A randomized, double‐blind, placebo‐controlled cross‐over trial evaluating the effect of intranasal insulin on depressive symptoms in individuals with major depressive disorder insufficiently responsive to antidepressant therapy (2013). Here, INS is linked to major depressive disorder.